Brian Connelly

Partner | Corporate

About

Brian has over 25 years of experience in legal and business roles in the life sciences sector. His diverse background makes him a valuable partner for his clients. Brian has extensive experience assisting clients with the leasing, build out, and operation of R&D laboratories. He has drafted and negotiated leases in major life sciences markets across the United States, including the Greater Boston/Cambridge areas, New Jersey, Philadelphia, Raleigh, San Diego, San Francisco and Seattle. Brian also assists clients within the biopharmaceutical industry on a broad range of commercial and corporate matters but has a unique expertise assisting clients with CMC-related matters and supply chain and distribution arrangements for both clinical and commercial pharmaceutical products and devices.

  • Brian also currently serves as the CEO of TheracosBio, LLC, a Massachusetts-based commercial stage pharmaceutical company that provides cost-effective solutions to patients with Type 2 diabetes. Prior to that, Brian co-founded IncreVet, Inc., which developed the first FDA-approved oral treatment for feline diabetes before being acquired in early 2022. Brian has also held legal and business development roles within an S&P 500 diagnostics company.

Practices

  • Commercial Transactions

  • Emerging Companies

  • FDA

  • FinTech and Blockchain

  • Mergers and Acquisitions

  • Private Equity and Venture Capital

  • Real Estate

  • Technology

Admissions

  • Massachusetts

  • New Hampshire

Education

  • The George Washington University Law School

  • London School of Economics

  • Boston College

Law Firm Experience

  • Faber, Daeufer & Itrato PC

  • Foley Hoag LLP

Corporate Experience

  • TheracosBio – Chief Executive Officer

  • IncreVet, Inc. - Co-Founder and Chief Operating Officer

  • IDEXX Laboratories, Inc. - Senior Manager for Business Development & Associate General Counsel